Q4 2025 / Year End 2025
Fund IDraft39 review flags
Opening
# Hemrock Ventures — Fund I
Q4 2025 / Year End 2025 Portfolio Update
16Dear Limited Partners,
We are
pleased to share our Q4 2025 portfolio update for Fund I. The portfolio continues to perform well, with aggregate
gross MOIC of 2.63x across four active companies. Total invested capital stands at $8.15M with a current portfolio
FMV of $21.4M.
### Portfolio Highlights
- **RouteWise** remains our standout performer at 3.75x MOIC following
a strong Series B close
- **NovaTech** crossed $225K MRR with 88% YoY growth
- **AdVantage** reduced CAC by 25%
through self-serve onboarding
- **GreenLeaf Bio** secured NSF grant and is on track for EPA approval in Q2
2026
---
### NovaTech
NovaTech closed Q4 2025 with MRR reaching $225K, up 18% quarter-over-quarter and 88%
year-over-year. Net revenue retention remains strong at 125%, driven by the launch of their AI-powered churn
prediction module in October. The team expanded to 42 FTEs with key hires in enterprise sales. Cash position stands
at $3.2M with a 14-month runway. The company is in early conversations for a Series A+ round at a $45M pre-money
valuation. Key risk: concentration in mid-market SaaS segment.
---
### GreenLeaf Bio
GreenLeaf Bio made
significant progress on their EPA regulatory submission, which is now on track for Q2 2026 approval. The team
secured a $500K non-dilutive grant from the National Science Foundation. Revenue remains pre-commercial at
$15K/month from pilot partnerships. Headcount grew to 12 with two PhD-level scientists joining the R&D team. Cash
position of $580K provides approximately 8 months of runway. The company is exploring a bridge round to extend
runway through EPA approval.
---
### RouteWise
RouteWise delivered another strong quarter with ARR crossing
$8.5M, up 22% QoQ. The logistics optimization platform processed 2.1M routes in Q4, a 3x increase from Q4 2024.
Gross margins improved to 78% as infrastructure costs scaled sub-linearly. The Series B funding ($15M at $85M pre)
closed in November, extending runway to 24+ months. The team is expanding into European markets with a London office
opening in Q1 2026. Notable new clients include two Fortune 500 retailers.
---
### AdVantage
AdVantage
grew revenue to $180K MRR in Q4, up 12% from Q3. The ad-tech platform now serves 340 enterprise customers across
retail and e-commerce verticals. Customer acquisition cost decreased 25% following the launch of self-serve
onboarding. The team of 28 is focused on building programmatic TV capabilities for 2026. Cash position of $2.8M with
16 months runway. Exploring strategic partnerships with two major DSPs for distribution.
---
We appreciate
your continued partnership and look forward to discussing these results in our upcoming annual meeting.
Best
regards,
Hemrock Ventures
NovaTech
5NovaTech closed Q4 2025 with MRR reaching $225K, up 18% quarter-over-quarter and 88%
year-over-year. Net revenue retention remains strong at 125%, driven by the launch of their AI-powered churn
prediction module in October. The team expanded to 42 FTEs with key hires in enterprise sales. Cash position stands
at $3.2M with a 14-month runway. The company is in early conversations for a Series A+ round at a $45M pre-money
valuation. Key risk: concentration in mid-market SaaS segment.
GreenLeaf Bio
3GreenLeaf Bio made significant progress on their EPA regulatory submission, which
is now on track for Q2 2026 approval. The team secured a $500K non-dilutive grant from the National Science
Foundation. Revenue remains pre-commercial at $15K/month from pilot partnerships. Headcount grew to 12 with two
PhD-level scientists joining the R&D team. Cash position of $580K provides approximately 8 months of runway. The
company is exploring a bridge round to extend runway through EPA approval.
RouteWise
7RouteWise delivered another strong quarter with ARR crossing $8.5M, up 22% QoQ. The
logistics optimization platform processed 2.1M routes in Q4, a 3x increase from Q4 2024. Gross margins improved to
78% as infrastructure costs scaled sub-linearly. The Series B funding ($15M at $85M pre) closed in November,
extending runway to 24+ months. The team is expanding into European markets with a London office opening in Q1 2026.
Notable new clients include two Fortune 500 retailers.
AdVantage
7AdVantage grew revenue to $180K MRR in Q4, up 12% from Q3. The ad-tech platform now
serves 340 enterprise customers across retail and e-commerce verticals. Customer acquisition cost decreased 25%
following the launch of self-serve onboarding. The team of 28 is focused on building programmatic TV capabilities
for 2026. Cash position of $2.8M with 16 months runway. Exploring strategic partnerships with two major DSPs for
distribution.